Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 10 de 10
Filtre
1.
Rev. Col. Bras. Cir ; 40(2): 137-141, mar.-abr. 2013. ilus, tab
Article Dans Portugais | LILACS | ID: lil-676368

Résumé

OBJETIVO: Avaliar as repercussões hepáticas da carcinogênese colônica induzida por diferentes doses e tempos de exposição ao azoximetano em ratos Wistar. MÉTODOS: Quarenta e quatro ratos foram distribuídos em quatro grupos. Os animais tinham oito semanas no início do experimento. No grupo 1, receberam 1.0mL de solução salina intraperitonealmente uma vez por semana por duas semanas. No grupo 2, receberam 15 mg/kg de azoximetano intraperitonealmente uma vez por semana por duas semanas. Esses animais foram mortos na 15ª semana do experimento. Os animais do grupo 3 receberam solução salina intraperitonealmente uma vez por semana por duas semanas. Os animais do grupo 4 receberam 20mg/kg de azoximetano intraperitonealmente uma vez por semana por duas semanas. Esses animais foram mortos na 26ª semana do experimento. Os fragmentos de tecido hepático foram corados pela hematoxilina e eosina e avaliadas microscopicamente. RESULTADOS: Grupo 1 e grupo 2 diferiram significantemente em relação a esteatose, mas não houve diferença entre o grupo 3 e o grupo 4. No entanto, no grupo 4 foram observadas lesões pré-neoplásicas (focos de células alteradas, claras, vacuoladas, basofílicas, anfofílicas, tigróides, oncocíticas, pequenas ou acidófilas, espongioses e pelioses) e lesões neoplásicas (colangiomas e adenomas) contendo hepatócitos atípicos de permeio, não identificados no grupo 3. CONCLUSÃO: No modelo de carcinogênese colorretal, lesões hepáticas pré-neoplásicas e neoplásicas aparecem e evoluem na proporção do tempo e dose de exposição ao azoximetano.


OBJECTIVE: To evaluate the hepatic effects of colonic carcinogenesis induced by azoxymethane at different doses and times of exposure in rats. METHODS: Forty-four Wistar rats were divided into four groups. The animals were eight weeks at the beginning of the experiment. group 1 received 1.0ml of saline intraperitoneally once a week for two weeks. Group 2 received 15 mg/kg of azoxymethane intraperitoneally once a week for two weeks. These animals were killed at the 15th week of the experiment. The animals of group 3 received saline intraperitoneally once a week for two weeks. Group 4 animals received 20mg/kg of azoxymethane intraperitoneally once a week for two weeks. These animals were killed at the 26th week of the experiment. The fragments of liver tissue were stained with hematoxylin and eosin and evaluated microscopically. RESULTS: Groups 1 and 2 differed significantly in relation to steatosis, no difference having been found between group 3 and group 4. However, in group 4 we observed pre-neoplastic lesions (foci of altered, clear, vacuolated, basophilic, amphophilic tigroid, oncocytic, small or acidophilus cells, spongiosis and peliosis) and neoplastic lesions (adenomas and colangiomas) containing atypical hepatocytes in between, not identified in group 3. CONCLUSION: In the model of colorectal carcinogenesis, preneoplastic and neoplastic hepatic lesions appear and evolve in proportion to the time of exposure and dose of azoxymethane.


Sujets)
Animaux , Rats , Oxyde de diméthyl-diazène/administration et posologie , Carcinogenèse/effets des médicaments et des substances chimiques , Cancérogènes/administration et posologie , Tumeurs colorectales/induit chimiquement , Tumeurs colorectales/complications , Maladies du foie/étiologie , États précancéreux/étiologie , Oxyde de diméthyl-diazène/pharmacologie , Cancérogènes/pharmacologie , Maladies du foie/anatomopathologie , Rat Wistar
2.
Journal of Preventive Medicine and Public Health ; : 155-161, 2007.
Article Dans Anglais | WPRIM | ID: wpr-213281

Résumé

OBJECTIVES: Bisphenol A diglycidyl ether (BADGE) is the major component in commercial liquid epoxy resins, which are manufactured by co-reacting bisphenol A with epichlorohydrin. This study was performed to show the developmental effects of prenatal and postnatal exposures to BADGE in male rat offspring. METHODS: Mated female rats were divided into four groups, each containing 12 rats. The dosing solutions were prepared by thoroughly mixing BADGE in corn oil at the 0, 375, 1500 and 3000 mg/kg/day concentrations. Mated females were dosed once daily by oral gavage on gestation day (GD) 6 - 20 and postnatal day (PND) 0 - 21. Pregnant female dams were observed general symptoms and body weight. Also, male pups were observed the general symptoms, body weight, developmental parameters (e.g. anogenital distance, pina detachment, incisor eruption, nipple retention, eye opening, testis descent), organ pathologic changes and hormone levels of plasma. RESULTS: Pregnant rats treated with BADGE died at a rate of about 70% in the 1500 mg/kg/day group and all rats treated with 3000 mg/kg/day died. Body weight, for male pups treated with doses of 375 mg/kg/day, was significantly lower than in the control group at PND 42, 56, and 63 (p<0.05). Evaluation of body characteristics including; separation of auricle, eruption of incisor, separation of eyelid, nipple retention, descent of testis, and separation of the prepuce in the BADGE treated group showed no difference in comparisons with the control group. AGD and adjusted AGD (mm/kg) for general developmental items in BADGE 375 mg/kg/day treated pups tended to be longer than in controls, however, these differences were not statistically significant. Relative weights of adrenal gland, lung (p<0.05), brain, epididymis, prostate, and testis (p<0.01) were heavier than in control in measures at PND 9 weeks. There were no significant changes in comparisons of histological findings of these organs. Loss of spermatids was observed in the seminiferous tubule at PND 9 weeks, but no weight changes were observed. The plasma estrogen levels were similar in the control and treatment groups at PND 3, 6 and 9 weeks. The plasma testosterone levels in the control group tended to increase with age. However, in the BADGE 375 mg/kg/day treated male pups it did not tend to increase. CONCLUSIONS: These findings suggest that BADGE is a chemical that has developmental effects consistent with it being an endocrine disruptor.


Sujets)
Rats , Grossesse , Mâle , Femelle , Animaux , Rat Sprague-Dawley/croissance et développement , Corée , Composés époxy/administration et posologie , Cancérogènes/administration et posologie
3.
Article Dans Anglais | IMSEAR | ID: sea-37890

Résumé

The purpose of the present study was to examine whether Neem leaf (Azadirachta indica) has short-term chemopreventive effects on endpoint preneoplastic lesions involved in rat colon carcinogenesis and might also exert antioxidative activity. Forty- two male F344 rats were randomly divided into 6 experimental groups. Groups 1 to 4 were given a subcutaneous injection of azoxymethane (AOM, 20 mg/kg body weight) once a week for 2 weeks. Starting one week before the first injection of AOM, rats in groups 2 to 4 received an aqueous extract of Neem leaf (20, 100, and 250 mg/kg, respectively) by gavage 3 times per week, for 5 weeks. Rats in group 5 also were given the Neem extract by gavage feeding 3 times per week for 5 weeks, while group 6 served as untreated controls. The experiment was terminated 5 weeks after the start. Dietary feeding of the Neem extract at all dose levels significantly inhibited the induction of aberrant crypt foci (ACF) (P<0.0002), when compared to the AOM-treated group (group 1). In groups 2 to 4, treatment of rats with the Neem extract also significantly decreased the proliferating cell nuclear antigen (PCNA) labeling indices (P<0.0006) of colon epithelium and ACF. Moreover, the Neem extract also showed antioxidative activity. The finding that dietary Neem has possible chemopreventive effects in the present short-term colon carcinogenesis bioassay suggests that longer-term exposure may cause suppression of tumor development.


Sujets)
Animaux , Antioxydants/administration et posologie , Azadirachta/composition chimique , Oxyde de diméthyl-diazène/administration et posologie , Cancérogènes/administration et posologie , Transformation cellulaire néoplasique , Chimioprévention , Tumeurs du côlon/induit chimiquement , Mâle , Phytothérapie/médecine vétérinaire , Extraits de plantes/administration et posologie , États précancéreux/induit chimiquement , Rats , Rats de lignée F344
4.
Article Dans Anglais | IMSEAR | ID: sea-37829

Résumé

Phenobarbital (PB), a rodent non-genotoxic carcinogen, showed hormesis, biphasic effects on rat liver carcinogenesis. To test the hypothesis that the hormesis earlier observed for PB induced hepatocarcinogenesis might also exist in the TGF-alpha transgenic mice model, one which is highly susceptible to carcinogenesis, the carcinogenic or promotion effects of a wide range of phenobarbital (PB) concentrations were investigated. Two weeks after a single i.p. dose of 5 mg /kg bw of diethylnitrosamine (DEN) to 15 day old mice, animals were treated with diet containing PB at doses of 0, 2, 15 or 500 ppm. The incidence and multiplicity of tumors, including hepatocellular adenomas and carcinomas, were significantly increased by the high dose of PB, but no significant difference among the groups receiving 2 and 15 ppm for liver tumors when compared to DEN alone group. The proliferating cell nuclear antigen indices for liver tumors and surrounding hepatocytes in high dose PB treated mice were significantly increased, but no change was noted at the lower doses. The total cytochrome P450 content in the liver was also elevated by 500 ppm of PB, while hepatic 8-OHdG levels demonstrated no significant change. In conclusion, PB at high dose enhances DEN-induced hepatocarcinogenesis in TGF-alpha transgenic mice, but low doses lack any significant effects. One possible mechanism of phenobarbital carcinogenicity might be influenced by cytochrome P450 system exhibiting a strong promoting activity for liver of mice.


Sujets)
Animaux , Anticonvulsivants/administration et posologie , Tests de cancérogénicité , Cancérogènes/administration et posologie , N-Éthyl-N-nitroso-éthanamine/administration et posologie , Relation dose-effet des médicaments , Tumeurs du foie/induit chimiquement , Souris , Souris transgéniques , Phénobarbital/administration et posologie , Facteur de croissance transformant alpha/génétique
5.
Article Dans Anglais | IMSEAR | ID: sea-37713

Résumé

Prostaglandin E2, which is produced by cyclooxygenase (COX) during arachidonic acid metabolism, is considered to be related to colon carcinogenesis and selective COX-2 inhibitors may be effective for chemoprevention without the adverse side effects of non-selective, nonsteroid anti-inflammatory drugs. Therefore, the influence of JTE-522 (4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzensulfonamide), a selective COX-2 inhibitor, was examined in azoxymethane(AOM)-induced rat colon carcinogenesis. A total of 40 male F344 rats were randomly divided into two groups. Group 1 received diet containing 0.015% JTE-522 and group 2 the normal diet without supplement as a control group; one week later, all rats were administered axozymethane (AOM) s.c. at a dose of 15 mg/kg body weight once a week for 3 successive weeks. At the termination of the experiment (30 weeks after the start), the multiplicity of colon cancer in group 1 was significantly less than that of group 2. The proliferating cell nuclear antigen (PCNA) indices for non-neoplastic cells of the colon mucosa in group 1 were also lower. These data thus suggest that JTE-522 has chemopreventive potential against colon carcinogenesis with decrease of mucosal cell proliferation in rats.


Sujets)
Administration par voie orale , Aliment pour animaux , Animaux , Oxyde de diméthyl-diazène/administration et posologie , Benzènesulfonates/pharmacologie , Cancérogènes/administration et posologie , Transformation cellulaire néoplasique , Tumeurs du côlon/physiopathologie , Inhibiteurs des cyclooxygénases/pharmacologie , Muqueuse intestinale/cytologie , Mâle , Oxazoles/pharmacologie , Antigène nucléaire de prolifération cellulaire/analyse , Répartition aléatoire , Rats , Rats de lignée F344
6.
Article Dans Anglais | IMSEAR | ID: sea-37988

Résumé

One of the most promising strategies for cancer prevention today is chemoprevention using readily available natural substances from vegetables, fruits, herbs and spices. Among the spices, saffron (Crocus sativus, L) a member of the large family Iridaceae, has drawn attention because apart from its use as a flavouring agent, pharmacological studies have demonstrated many health promoting properties including radical scavenging, anti- mutagenic and immuno-modulating effects. In the present study the effects of an aqueous infusion of saffron on two stage skin papillogenesis / carcinogenesis in mice initiated by 7-12 dimethyl benz[a] anthracin (DMBA) and promoted with croton oil were investigated. Significant reduction in papilloma formation was found with saffron application in the pre-initiation and post-initiation periods, and particular when the agent was given both pre- and post-initiation. The inhibition appeared to be at least partly due on modulatory effects of saffron on some phase II detoxifying enzymes like glutathione-S-transferase (GST) and glutahinoe peroxidase (GPx), as well as catalase (CAT) and superoxide dismutase (SOD).


Sujets)
7,12-Diméthyl-benzo[a]anthracène/administration et posologie , Animaux , Cancérogènes/administration et posologie , Transformation cellulaire néoplasique , Crocus/composition chimique , Femelle , Souris , Tumeurs expérimentales , Papillome/prévention et contrôle , Préparations à base de plantes/pharmacologie , Tumeurs cutanées/prévention et contrôle
8.
Indian J Exp Biol ; 1991 Sep; 29(9): 813-7
Article Dans Anglais | IMSEAR | ID: sea-58964

Résumé

Subacute doses (1/20 LD50) of aflatoxin B1 and ochratoxin A were fed to weanling albino rats individually and in combination for 36 weeks and then rats were maintained on toxin free normal diet for a period of 24 weeks. Livers of rats were fatty, wherever aflatoxin was administered but the enzyme activity did not show significant differences among various groups. However, in a few individuals whose livers were severely affected, higher concentrations of urine creatinine, liver RNA and DNA, and ALT enzyme activity were recorded. Histopathological examination showed various stages of hepatoma and hepatocarcinoma including nodular hyperplasia, hypertrophy, vacuolisation, degeneration, pseudolobulation, cellular infiltration and fibrosis of liver of rats fed with aflatoxin individually and in combination. Few anaplastic cells in the corticomedullary region and nuclear enlargement of proximal tubular epithelium of kidney were found wherever combined toxin and ochratoxin alone were administered. Liver tumor expression was time dependent.


Sujets)
Administration par voie orale , Aflatoxine B1/administration et posologie , Animaux , Cancérogènes/administration et posologie , Transformation cellulaire néoplasique/effets des médicaments et des substances chimiques , Rein/cytologie , Mâle , Ochratoxines/administration et posologie , Rats , Lignées consanguines de rats
9.
Rev. bras. cir ; 81(3): 137-9, mai.-jun. 1991.
Article Dans Portugais | LILACS | ID: lil-100007

Résumé

A elevada incidência de desenvolvimento de câncer no estômago operado por doença benigna tem sido enfatizada por vários autores, nos últimos anos. Especulam-se o papel de bactérias nitrato-redutoras que proliferam em meio alcalino na N-nitrosaçäo de nitratos e formaçäo intragástrica de nitrosaminas, substâncias comprovadamente carcinogênicas. Atualmente existe uma tendência à definiçäo de grupos de risco de desenvolvimento de câncer gástrico entre os pacientes operados por doença gastroduodenal benigna. Em virtude da invabilidade de um seguimento indiscriminado de todos os pacientes enquadrados nesta situaçäo clínica, sugere-se que seja realizado um controle endoscópico rigoroso em determinados grupos de pacientes. Alguns aspectos de carcinogênese no estômago operado säo comentados


Sujets)
Humains , Tumeurs de l'abdomen/chirurgie , Industrie chimique , Estomac/chirurgie , Groupes à Risque/analyse , Tumeurs de l'estomac , Brésil , Cancérogènes/administration et posologie , Nitrosamines
SÉLECTION CITATIONS
Détails de la recherche